A carregar...

Adjuvant treatment of non-small cell lung cancer: focus on targeted therapy

In patients with completely resected stage II-IIIA non-small cell lung cancer (NSCLC), adjuvant platinum-based chemotherapy is associated with a modest, albeit significant, improvement in survival of approximately 5% at 5 years. However, regardless of whether adjuvant chemotherapy has been administe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Tazza, Marco, Metro, Giulio
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723861/
https://ncbi.nlm.nih.gov/pubmed/29268417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.08.130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!